• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX Back to Search Results
Model Number CDK-1413
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Pleural Effusion (2010); Pericardial Effusion (3271)
Event Date 11/10/2017
Event Type  Death  
Manufacturer Narrative
(b)(4).The device was not returned for evaluation as this adverse event occurred post-operation.No product history review was able to be performed as no lot number was reported for this device.There was no device malfunction reported during the initial procedure.
 
Event Description
On (b)(6) 2017, a (b)(6) male patient received an off-pump convergent epicardial/endocardial ablation procedure using an episense guided coagulation system (cdk-1413) and the patient was discharged on (b)(6) 2017.On (b)(6) 2017, the patient presented to the er with shortness of breath, peripheral edema and chest pain.The patient¿s chest x-ray was clear with no pleural effusion.However, a ct scan performed revealed small left and trace right pleural effusion, with small pericardial effusion.The patient was placed under observation, treated with an iv diuretic and discharged with major improvement in condition.On (b)(6) 2017, an echo performed on the patient showed no pericardial or pleural effusion.On (b)(6) 2017, the patient returned to his primary care physician who reported an ef 55%, and the patient was directed to consult with the cardiac surgeon on administration of medicine.The diuretic was increased to 80mg for the day, and then returned to 40mg/day.On (b)(6) 2017, the patient returned to the er presenting with afib and chf exacerbation.His white cell blood count was 19.7 and chest x-ray indicated his lungs were clear and unremarkable.The patient was kept in the hospital overnight for observation.On (b)(6) 2017, while being prepared for cardioversion, the patient stopped breathing, lost pulse, and was unresponsive.After unsuccessful attempts at reviving, the patient passed away on (b)(6) 2017.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX
Type of Device
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX
Manufacturer (Section D)
ATRICURE, INC.
7555 innovation way
mason OH 45040
Manufacturer (Section G)
ATRICURE, INC.
7555 innovation way
mason OH 45040
Manufacturer Contact
anupam bedi
MDR Report Key7110247
MDR Text Key94573334
Report Number3011706110-2017-00104
Device Sequence Number1
Product Code OCL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142084
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/12/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other Health Care Professional
Device Model NumberCDK-1413
Device Catalogue NumberCDK-1413
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/13/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age69 YR
Patient Weight160
-
-